Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/1999
06/24/1999WO1999031075A1 1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/24/1999WO1999031074A2 ((cyclo)alkyl substituted)-.gamma.-aminobutyric acid derivatives (=gaba analogues), their preparation and their use in the treatment of neurological disorders
06/24/1999WO1999031066A1 Pyridones as src family sh2 domain inhibitors
06/24/1999WO1999031061A1 Integrin receptor antagonists
06/24/1999WO1999031058A1 Novel heterocyclic compounds
06/24/1999WO1999031057A1 4(3)substituted-4(3)-aminomethyl-(thio)pyran or -piperidine derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders
06/24/1999WO1999030729A1 Compositions and methods for regulating phagocytosis and icam-1 expression
06/24/1999WO1999030713A1 Integrin receptor antagonists
06/24/1999WO1999030710A1 USE OF PYRAZOLO [3,4-b] PYRIDINE AS CYCLIN DEPENDENT KINASE INHIBITORS
06/24/1999WO1999030709A1 Integrin receptor antagonists
06/24/1999WO1999030703A1 Use of formoterol in medicament for inflammation/allergy in upper airways
06/24/1999WO1999030670A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
06/24/1999CA2315370A1 Integrin receptor antagonists
06/24/1999CA2315295A1 110 human secreted proteins
06/24/1999CA2315232A1 Integrin receptor antagonists
06/24/1999CA2314899A1 Compositions and methods for regulating phagocytosis and icam-1 expression
06/24/1999CA2314885A1 Pharmaceutical compositions for mucolysis and treatment of inflammation
06/24/1999CA2314379A1 Human dendriac and brainiac-3
06/24/1999CA2314355A1 Use of pyrazolo ¢3,4-b! pyridine as cyclin dependent kinase inhibitors
06/24/1999CA2314335A1 Purine derivatives having phosphodiesterase iv inhibition activity
06/24/1999CA2313651A1 Benzamine derivatives
06/24/1999CA2313239A1 Azulene hydroxamic acid derivatives as metalloprotein inhibitors
06/24/1999CA2313004A1 3-substituted adenines via2-thioxanthines
06/23/1999EP0924297A1 Sialoadhesin family member-2 (saf-2)
06/23/1999EP0923646A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis
06/23/1999EP0923585A1 Phosphinate based inhibitors of matrix metalloproteases
06/23/1999EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives
06/23/1999EP0923568A1 Novel benzofuran-4-carboxamides
06/23/1999EP0923563A1 1,4-heterocyclic metallprotease inhibitors
06/23/1999EP0923550A1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists
06/23/1999EP0923547A1 Bidentate metalloprotease inhibitors
06/23/1999EP0923546A1 Acylpyrroldicarboxylic acids and acylindoldicarboxylic acids and their derivatives and inhibitors of the cytosolic phospholipase a2
06/23/1999EP0923530A1 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
06/23/1999EP0923529A1 Subsitute 4-arylbutyric acid derivatives as matrix metalloprotease inhibitors
06/23/1999EP0923377A1 Therapeutic uses for an aminosterol compound
06/23/1999EP0923373A1 Il-8 receptor antagonists
06/23/1999CN1220660A Alkyloxyamino substituted fluorenones and their use as protein kinase cinhibitors
06/23/1999CN1220656A Novel trienoic retinoid compounds and method
06/23/1999CN1220266A Intermediates of protein kinase C inhibitors and preparation process thereof
06/23/1999CN1043761C Fluorinated hydroxyalkylquinoline acid and medicinal salt and its drug composition
06/23/1999CA2222770A1 Method of treating rheumatoid arthritis with low dose type ii collagen
06/22/1999US5914425 Modifications of 2-amino-4-(4-5fluorobenzylamino)-1-ethoxycarbonylaminobenzene, and processes for their preparation
06/22/1999US5914406 Azepanes and their ring homologues having protein kinase inhibiting activity
06/22/1999US5914325 Steroids with radical-attracting aromatic substituents, process for the production thereof and pharmaceutical compounds containing the said substances
06/22/1999US5914314 Hyaluronic acid and its nontoxic salts facilitate penetration of immunosuppressent through underperfused or pathological tissue, including scar tissue
06/22/1999US5914118 Multi-layered drug containing film preparation having powder adhesive thereon
06/22/1999US5914111 Inhibiting t-cell activation by administering polypeptide having amino acids 1-92 of lymphocyte functioning associated antigen-3 joined to different protein or polypeptide comprising portion of immunoglobulin
06/22/1999US5914106 Interleukin-6 receptor agonists
06/22/1999CA2169066C Phenoxyphenyl cyclopentenyl hydroxyureas
06/22/1999CA2151674C Methods of administering crf antagonists
06/20/1999CA2255143A1 Binding partners for inhibitors of cyclin-dependent kinases and their use for searching for inhibitors and for the diagnosis or therapy of a disease
06/20/1999CA2255141A1 Nucleic acid constructs for gene therapy whose activity is affected by inhibitors of cyclin-dependent kinases
06/17/1999WO1999030157A2 Neuropilins in methods for diagnosis and prognosis of cancer
06/17/1999WO1999029878A2 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999WO1999029861A1 Peptide antagonists of vascular endothelial growth factor
06/17/1999WO1999029858A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/17/1999WO1999029856A1 Restin and methods of use thereof
06/17/1999WO1999029855A1 Mutants of endostatin, 'em 1' having anti-angiogenic activity and methods of use thereof
06/17/1999WO1999029694A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999WO1999029693A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
06/17/1999WO1999029667A1 Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors
06/17/1999WO1999029661A1 Adamantane derivatives
06/17/1999WO1999029660A1 Adamantane derivatives
06/17/1999WO1999029339A2 Prevention and/or treatment of allergic conditions
06/17/1999WO1999029316A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
06/17/1999WO1999029173A1 Composition useful for providing one-step surgical preparation and drape
06/17/1999WO1999017796A3 Modulation of lerk-2-mediated cell adhesion
06/17/1999WO1999017787A3 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/17/1999WO1999015198A3 Agents for combating bacterial meningitis
06/17/1999WO1999013064A3 Viral infection of cells using viral vectors
06/17/1999WO1999009162A3 Delayed progression to aids by a missense allele of the ccr2 gene
06/17/1999WO1998018823A8 Ice inhibiting peptides
06/17/1999DE19755268A1 Benzamidinderivate Benzamidine derivatives
06/17/1999CA2313705A1 Restin and methods of use thereof
06/17/1999CA2313390A1 Peptide antagonists of vascular endothelial growth factor
06/17/1999CA2313348A1 Soluble inhibitors of vascular endothelial growth factor and use thereof
06/17/1999CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof
06/17/1999CA2313150A1 Purine compounds having pde iv inhibitory activity and methods of synthesis
06/17/1999CA2312889A1 Adamantane derivatives
06/17/1999CA2312420A1 Adamantane derivatives
06/17/1999CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system
06/17/1999CA2309686A1 Composition useful for providing one-step surgical preparation and drape
06/16/1999EP0922762A1 Drug binding protein
06/16/1999EP0922702A1 Azulene derivatives and pharmaceutical compositions containing them
06/16/1999EP0922107A1 Human kallikrein
06/16/1999EP0922100A2 Secreted proteins and polynucleotides encoding them
06/16/1999EP0922042A1 Novel piperazine containing compounds
06/16/1999EP0922036A1 Arylalkanoyl pyridazines
06/16/1999EP0922028A1 Inhibitors of phospholipase enzymes
06/16/1999EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids
06/16/1999EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin
06/16/1999EP0921802A1 Method for treating pain
06/16/1999EP0921785A1 Combination of acid protease enzymes and acidic buffers and uses thereof
06/16/1999CN1219935A Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
06/16/1999CN1219934A Novel pyridazine compounds
06/16/1999CN1219929A Urea derivatives as inhibitors of IMPDH enzyme
06/16/1999CN1219928A Novel vitamin D analogues
06/16/1999CN1219924A Colchicine-skeleton compounds, their use as medicaments and compounds containing them
06/16/1999CN1219877A Method for treating pain
06/16/1999CN1043639C New piperidine compounds, process for their preparation and pharmaceutical compositions which contain them
1 ... 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 ... 1272